Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

OBJECTIVE: To determine the efficacy and safety of fremanezumab administration in Japanese and Korean patients with chronic migraine (CM). BACKGROUND: Available preventive treatments for CM are limited by various efficacy and safety issues. Fremanezumab, a monoclonal antibody that targets the calcit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Fumihiko, Suzuki, Norihiro, Kim, Byung‐Kun, Igarashi, Hisaka, Hirata, Koichi, Takeshima, Takao, Ning, Xiaoping, Shima, Tomoko, Ishida, Miki, Iba, Katsuhiro, Kondo, Hiroyuki, Koga, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456899/
https://www.ncbi.nlm.nih.gov/pubmed/34324700
http://dx.doi.org/10.1111/head.14169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456899/
https://www.ncbi.nlm.nih.gov/pubmed/34324700
http://dx.doi.org/10.1111/head.14169

Ejemplares similares